Literature DB >> 23301545

RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.

S Marton1, C Romero-López, A Berzal-Herranz.   

Abstract

The RNA genome of hepatitis C virus (HCV) contains multiple conserved structural RNA domains that play key roles in essential viral processes. A conserved structural component within the 3' end of the region coding for viral RNA-dependent RNA polymerase (NS5B) has been characterized as a functional cis-acting replication element (CRE). This study reports the ability of two RNA aptamers, P-58 and P-78, to interfere with HCV replication by targeting the essential 5BSL3.2 domain within this CRE. Structure-probing assays showed the binding of the aptamers to the CRE results in a structural reorganization of the apical portion of the 5BSL3.2 stem-loop domain. This interfered with the binding of the NS5B protein to the CRE and induced a significant reduction in HCV replication (≈50%) in an autonomous subgenomic HCV replication system. These results highlight the potential of this CRE as a target for the development of anti-HCV therapies and underscore the potential of antiviral agents based on RNA aptamer molecules.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23301545     DOI: 10.1111/j.1365-2893.2012.01629.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  12 in total

Review 1.  Prospects for nucleic acid-based therapeutics against hepatitis C virus.

Authors:  Chang Ho Lee; Ji Hyun Kim; Seong-Wook Lee
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

2.  Inhibition of HCV translation by disrupting the structure and interactions of the viral CRE and 3' X-tail.

Authors:  Andrew Tuplin; Madeleine Struthers; Jonathan Cook; Kirsten Bentley; David J Evans
Journal:  Nucleic Acids Res       Date:  2015-02-20       Impact factor: 16.971

3.  The cis-acting replication element of the Hepatitis C virus genome recruits host factors that influence viral replication and translation.

Authors:  Pablo Ríos-Marco; Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

4.  Isolation of an Aptamer that Binds Specifically to E. coli.

Authors:  Soledad Marton; Fernanda Cleto; Marco Aurélio Krieger; Josiane Cardoso
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

Review 5.  Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.

Authors:  Víctor M González; M Elena Martín; Gerónimo Fernández; Ana García-Sacristán
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-16

Review 6.  Functional Information Stored in the Conserved Structural RNA Domains of Flavivirus Genomes.

Authors:  Alba Fernández-Sanlés; Pablo Ríos-Marco; Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Front Microbiol       Date:  2017-04-03       Impact factor: 5.640

7.  Aptamer-based therapeutics: new approaches to combat human viral diseases.

Authors:  Ka-To Shum; Jiehua Zhou; John J Rossi
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-25

8.  RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region.

Authors:  Alba Fernández-Sanlés; Beatriz Berzal-Herranz; Rodrigo González-Matamala; Pablo Ríos-Marco; Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Molecules       Date:  2015-09-02       Impact factor: 4.411

Review 9.  Unmasking the information encoded as structural motifs of viral RNA genomes: a potential antiviral target.

Authors:  Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Rev Med Virol       Date:  2013-08-27       Impact factor: 6.989

10.  Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein.

Authors:  Chang Ho Lee; Soo-Han Lee; Ji Hyun Kim; Yook-Hwan Noh; Gyu-Jeong Noh; Seong-Wook Lee
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-06       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.